FINWIRES · TerminalLIVE
FINWIRES

RBC Capital Cuts bioMérieux PT, Affirms Sector Perform Rating

By

RBC Capital on Monday reduced the price target for biotechnology company bioMérieux (BIM.PA) to 75 euros from 100 euros, while keeping its sector perform rating.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles